Valuation: SSY Group Limited

Market Cap 6.13B 782M 684M 632M 589M 1.11B 73.91B 1.13B 7.58B 2.94B 36.47B 2.94B 2.87B 127B P/E 2026 *
10.9x
P/E 2027 * 8.83x
Enterprise Value 6.13B 782M 684M 632M 589M 1.11B 73.91B 1.13B 7.58B 2.94B 36.47B 2.94B 2.87B 127B EV / Sales 2026 *
1.26x
EV / Sales 2027 * 1.11x
Free-Float
33.48%
Yield 2026 *
4.7%
Yield 2027 * 5.51%
1 day-1.85%
1 week+4.95%
Current month-9.01%
1 month-9.01%
3 months-11.67%
6 months-26.39%
Current year-25.09%
1 week 2.08
Extreme 2.08
2.27
1 month 2.01
Extreme 2.01
2.4
Current year 2.01
Extreme 2.01
3.15
1 year 2.01
Extreme 2.01
3.4
3 years 2.01
Extreme 2.01
5.2
5 years 2.01
Extreme 2.01
8.29
10 years 2.01
Extreme 2.01
9.46
Manager TitleAgeSince
Chief Executive Officer 69 2010-03-22
Director of Finance/CFO 45 2015-03-31
Corporate Officer/Principal 42 2024-08-27
Director TitleAgeSince
Chairman 69 2014-06-03
Director/Board Member 61 2007-07-25
Director/Board Member 57 2005-10-15
Date Insider Type Main position Quantity % Market Cap.
05-20Other

Chief Executive Officer

1,300,000 0.0441%
05-18Other

Chief Executive Officer

2,000,000 0.0678%
05-17Other

Chief Executive Officer

2,500,000 0.0847%
Change 5-day change 1-year change 3-year change Capi.($)
-1.85%+4.95%-22.91%-57.17% 796M
-2.48%+8.83%+54.68%+158.23% 1,097B
-1.76%+9.81%+66.64%+54.77% 622B
-1.05%+9.40%+38.03%+88.88% 449B
+0.83%+6.34%+29.51%+24.01% 334B
-1.38%+6.09%+37.91%+25.49% 294B
+0.30%+5.24%+31.61%+42.02% 286B
-0.10%+4.88%-28.09%-41.02% 213B
+0.44%+5.05%+30.67%+63.74% 195B
+0.01%+1.18%+14.16%+66.21% 157B
Average -0.67%+6.80%+25.22%+42.51% 364.75B
Weighted average by Cap. -1.12%+8.72%+41.33%+79.25%

Financials

2026 *2027 *
Net sales 4.87B 621M 543M 501M 468M 881M 58.68B 897M 6.01B 2.34B 28.96B 2.33B 2.28B 101B 5.51B 703M 615M 568M 530M 998M 66.45B 1.02B 6.81B 2.64B 32.79B 2.64B 2.58B 114B
Net income 587M 74.86M 65.53M 60.49M 56.42M 106M 7.08B 108M 726M 282M 3.49B 281M 275M 12.17B 702M 89.46M 78.3M 72.28M 67.43M 127M 8.46B 129M 867M 337M 4.17B 336M 329M 14.54B
Net Debt - -
Logo SSY Group Limited
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Employees
5,472
Date Price Change Volume
26-06-30 HK$2.120 -1.85% 3,008,000
26-06-29 HK$2.160 +2.37% 2,618,000
26-06-26 HK$2.110 -2.31% 4,325,215
26-06-25 HK$2.160 -2.26% 4,209,996
26-06-24 HK$2.210 +1.84% 7,666,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.120HKD
Average target price
3.760HKD
Spread / Average Target
+77.36%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2005 Stock